DECREASED ALBUMINURIA BY PRAVASTATIN IN HYPERLIPIDEMIC DIABETICS

被引:43
作者
SHOJI, T
NISHIZAWA, Y
TOYOKAWA, A
KAWAGISHI, T
OKUNO, Y
MORII, H
机构
来源
NEPHRON | 1991年 / 59卷 / 04期
关键词
D O I
10.1159/000186665
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:664 / 665
页数:2
相关论文
共 9 条
[1]  
DULLAART RPF, 1989, DIABETOLOGIA, V32, P685
[2]  
FELDTRASMUSSEN B, 1986, LANCET, V2, P1300
[3]  
KEVIN PG, 1990, AM J KIDNEY DIS, V15, P16
[4]  
MOGENSEN CE, 1985, HYPERTENSION, V7, P64
[5]  
MORGENSEN CE, 1984, NEW ENGL J MED, V310, P356
[6]   PARTIAL REMISSION OF NEPHROTIC SYNDROME IN PATIENT ON LONG-TERM SIMVASTATIN [J].
RABELINK, AJ ;
HENE, RJ ;
ERKELENS, DW ;
JOLES, JA ;
KOOMANS, HA .
LANCET, 1990, 335 (8696) :1045-1046
[7]   RECEPTOR-MEDIATED ENDOCYTOSIS OF LOW-DENSITY-LIPOPROTEIN BY CULTURED HUMAN GLOMERULAR CELLS [J].
RAYNER, HC ;
HORSBURGH, T ;
BROWN, SL ;
LAVENDER, FL ;
WINDER, AF ;
WALLS, J .
NEPHRON, 1990, 55 (03) :292-299
[8]   ENALAPRIL REDUCES MICROALBUMINURIA IN YOUNG NORMOTENSIVE TYPE-1 (INSULIN-DEPENDENT) DIABETIC-PATIENTS IRRESPECTIVE OF ITS HYPOTENSIVE EFFECT [J].
RUDBERG, S ;
APERIA, A ;
FREYSCHUSS, U ;
PERSSON, B .
DIABETOLOGIA, 1990, 33 (08) :470-476
[9]  
VEBERTI GC, 1982, LANCET, V1, P1430